Squarepoint’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.6M Buy
60,496
+44,296
+273% +$1.15M ﹤0.01% 2376
2026
Q2
$423K Sell
16,200
-66,946
-81% -$1.7M ﹤0.01% 3552
2026
Q1
$2.08M Buy
+83,146
New +$1.97M ﹤0.01% 2149
2025
Q4
– Sell
-219,948
Closed -$3.76M – 5010
2025
Q3
$3.76M Buy
219,948
+64,349
+41% +$921K ﹤0.01% 1635
2025
Q2
$1.95M Buy
155,599
+91,997
+145% +$1.1M ﹤0.01% 2122
2025
Q1
$758K Buy
+63,602
New +$867K ﹤0.01% 2901
2024
Q4
– Sell
-33,438
Closed -$420K – 5574
2024
Q3
$420K Sell
33,438
-39,886
-54% -$434K ﹤0.01% 3227
2024
Q2
$624K Buy
73,324
+58,716
+402% +$523K ﹤0.01% 2910
2024
Q1
$154K Buy
+14,608
New +$162K ﹤0.01% 3699
2023
Q2
– Sell
-78,504
Closed -$710K – 4096
2023
Q1
$710K Buy
+78,504
New +$685K ﹤0.01% 2102
2022
Q3
– Sell
-235,285
Closed -$1.25M – 3524
2022
Q2
$1.25M Buy
+235,285
New +$1.42M 0.01% 1469
2021
Q3
– Sell
-28,975
Closed -$1M – 3511
2021
Q2
$1M Buy
28,975
+18,984
+190% +$602K ﹤0.01% 1626
2021
Q1
$316K Buy
+9,991
New +$406K ﹤0.01% 2358
2020
Q4
– Sell
-8,806
Closed -$410K – 3315
2020
Q3
$410K Sell
8,806
-8,456
-49% -$290K 0.01% 1582
2020
Q2
$623K Buy
17,262
+3,746
+28% +$138K 0.01% 1184
2020
Q1
$479K Buy
13,516
+1,916
+17% +$78.4K 0.01% 1069
2019
Q4
$527K Buy
+11,600
New +$422K ﹤0.01% 1750
2018
Q4
– Sell
-30,097
Closed -$473K – 2280
2018
Q3
$473K Sell
30,097
-8,534
-22% -$122K 0.01% 1324
2018
Q2
$571K Buy
+38,631
New +$598K 0.01% 1128

Other funds holding ZYME

Squarepoint's ZYME Position: Q3 2026 in Review

Squarepoint increased its Zymeworks (ZYME) stake by 273% in Q3 2026, buying an estimated $1.15M and bringing the position to 60,496 shares worth $1.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2376.

Squarepoint first reported a position in ZYME in Q2 2018 and has held it in 19 quarters since. The position peaked at $3.76M in Q3 2025. 203 funds tracked by Wall St. Rank hold ZYME as of Q3 2026.

  • Squarepoint held 60,496 shares of Zymeworks worth $1.6M as of Q3 2026.
  • Squarepoint bought 44,296 Zymeworks shares in Q3 2026, an estimated $1.15M.
  • Zymeworks made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #2376 holding.
  • Squarepoint first reported a position in Zymeworks in Q2 2018 and has held it in 19 quarters since.
  • Squarepoint's Zymeworks position peaked at $3.76M in Q3 2025.
  • 203 funds tracked by Wall St. Rank held Zymeworks as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.